Kapoor Alok, Patel Parth, Chennupati Soumya, Mbusa Daniel, Sadiq Hammad, Rampam Sanjeev, Leung Robert, Miller Megan, Vargas Kevin Rivera, Fry Patrick, Lowe Mary Martin, Catalano Christina, Harrison Charles, Catanzaro John Nicholas, Crawford Sybil, Smith Anne Marie
University of Massachusetts Chan Medical School, Worcester, MA, United States.
University of Massachusetts Memorial Health Care, Worcester, MA, United States.
JMIR Cardio. 2024 Jan 24;8:e49590. doi: 10.2196/49590.
The gap in anticoagulation use among patients with atrial fibrillation (AF) is a major public health threat. Inadequate patient education contributes to this gap. Patient portal-based messaging linked to educational materials may help bridge this gap, but the most effective messaging approach is unknown.
This study aims to compare the responsiveness of patients with AF to an AF or anticoagulation educational message between 2 portal messaging approaches: sending messages targeted at patients with upcoming outpatient appointments 1 week before their scheduled appointment (targeted) versus sending messages to all eligible patients in 1 blast, regardless of appointment scheduling status (blast), at 2 different health systems: the University of Massachusetts Chan Medical School (UMass) and the University of Florida College of Medicine-Jacksonville (UFL).
Using the 2 approaches, we sent patient portal messages to patients with AF and grouped patients by high-risk patients on anticoagulation (group 1), high-risk patients off anticoagulation (group 2), and low-risk patients who may become eligible for anticoagulation in the future (group 3). Risk was classified based on the congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age between 65 and 74 years, and sex category (CHADS-VASc) score. The messages contained a link to the Upbeat website of the Heart Rhythm Society, which displays print and video materials about AF and anticoagulation. We then tracked message opening, review of the website, anticoagulation use, and administered patient surveys across messaging approaches and sites using Epic Systems (Epic Systems Corporation) electronic health record data and Google website traffic analytics. We then conducted chi-square tests to compare potential differences in the proportion of patients opening messages and other evaluation metrics, adjusting for potential confounders. All statistical analyses were performed in SAS (version 9.4; SAS Institute).
We sent 1686 targeted messages and 1450 blast messages. Message opening was significantly higher with the targeted approach for patients on anticoagulation (723/1156, 62.5% vs 382/668, 57.2%; P=.005) and trended the same in patients off anticoagulation; subsequent website reviews did not differ by messaging approach. More patients off anticoagulation at baseline started anticoagulation with the targeted approach than the blast approach (adjusted percentage 9.3% vs 2.1%; P<.001).
Patients were more responsive in terms of message opening and subsequent anticoagulation initiation with the targeted approach.
心房颤动(AF)患者在抗凝治疗使用方面的差距是一项重大的公共卫生威胁。患者教育不足导致了这一差距。与教育材料相关联的基于患者门户网站的信息传递可能有助于弥合这一差距,但最有效的信息传递方式尚不清楚。
本研究旨在比较两种门户网站信息传递方式下心房颤动患者对房颤或抗凝教育信息的反应性:在预定门诊预约前1周向即将进行门诊预约的患者发送针对性信息(针对性方式)与向所有符合条件的患者一次性发送信息(群发方式),无论预约安排状态如何,在两个不同的医疗系统中进行:马萨诸塞大学陈医学院(UMass)和佛罗里达大学杰克逊维尔医学院(UFL)。
我们使用这两种方式向房颤患者发送患者门户网站信息,并将患者按抗凝治疗的高危患者(第1组)、未进行抗凝治疗的高危患者(第2组)以及未来可能符合抗凝治疗条件的低危患者(第3组)进行分组。风险根据充血性心力衰竭、高血压、年龄≥75岁、糖尿病、中风、血管疾病、年龄在65至74岁之间以及性别类别(CHADS-VASc)评分进行分类。信息包含指向心律协会乐观网站的链接,该网站展示有关房颤和抗凝治疗的印刷和视频材料。然后,我们使用Epic Systems(Epic Systems Corporation)电子健康记录数据和谷歌网站流量分析,跟踪信息的打开情况、网站浏览情况、抗凝治疗的使用情况,并在不同的信息传递方式和站点进行患者调查。然后进行卡方检验,以比较打开信息的患者比例和其他评估指标的潜在差异,并对潜在混杂因素进行调整。所有统计分析均在SAS(版本9.4;SAS Institute)中进行。
我们发送了1686条针对性信息和1450条群发信息。对于接受抗凝治疗的患者,针对性方式的信息打开率显著更高(723/1156,62.5%对382/668,57.2%;P = 0.005),未接受抗凝治疗的患者也呈现相同趋势;随后的网站浏览情况在不同信息传递方式之间没有差异。与群发方式相比,基线时未接受抗凝治疗的更多患者通过针对性方式开始接受抗凝治疗(调整后百分比9.3%对2.1%;P < 小于0.001)。
在信息打开和随后的抗凝治疗启动方面,患者对针对性方式的反应性更高。